Swiss Franc
Die SNB hält die Zinssätze bei null, da Spekulationen über Zinserhöhungen schwelen
Die Schweizerische Nationalbank hat ihren Leitzinssatz bei 0,00% gehalten und ihren Inflationsausblick verbessert, obwohl die Ökonomen sich bezüglich des Zeitpunkts oder sogar der Tatsache, ob es zu einer Zinssatzanhebung komme wird, uneins sind.
Der SMI hält sich stabil; UBS und Givaudan nachgefragt; Aktien aus dem Semiconductor-Sektor steigen; Nestlé unterperformt
Die Schweizer Börse zeigt leichte Gewinne; UBS und Givaudan stossen auf erhöhten Interessensdruck; Semikontektoraktien steigen; Nestlé schneidet unter; neue Bewertungen und Kursziele für Schweizer Aktien
Der SMI bleibt stabil; ABB und UBS steigen, Nestlé kämpft
Die Schweizer Börse zeigt sich nach wie vor robust, ABB und UBS gewinnen, Nestlé liegt dagegen zurück. Ölpreise und Zinserträge bleiben die wichtigsten Marktrückkehrfaktoren.
Schweizer Aktien für höheren Eröffnungsschlusskurs bereit, SNB hält die Zinssätze
Der SMI steht zu Beginn des Tages 0,4 % höher, da UBS Glencore aufhebt und Analysten die Ziele für Schweizer Aktien revidieren. Die SNB lässt die Zinsen bei null Prozent, während die Ölpreise zurückgehen.
Die Schweiz ist reich – warum sind die Schweizer Investoren dennoch so zurückhaltend?
Die Schweiz ist eines der reichsten Länder der Welt.
Die SNB behält die nullprozentigen Zinsen bei, obwohl die Inflationsüberwache deutlich ist, und verteidigt die UBS-Haftungsregeln
Die Schweizerische Nationalbank lässt den Leitzins unverändert bei 0 % und lehnt trotz Inflationsdruck und einer schwachen Franken-Kurse Forderungen nach Zinserhöhungen ab.
Bitcoins langfristige Abschottung vor steigenden Anleihezinsen bleibt bestehen, zeigt die Datenanalyse
Trotz eines Anstiegs der weltweiten Renditen um über 500 Basispunkte seit 2021 ist der Preis von Bitcoin um 191 % gestiegen, mit minimaler Korrelation zu Renditebewegungen.
UBS muss strengere Kapitalregeln einhalten; Schweizer Jobs gefährdet
Der Ständerat stimmte mit 33 gegen 10 für die Anforderung, dass UBS ihre ausländischen Tochtergesellschaften mit 90% an Kapital stärkt – ein Schritt, den Finanzminister Keller-Sutter lobt, der jedoch bis zu 10 000 Schweizer Arbeitsplätze kosten könnte.
Die Schweizerische Nationalbank (SNB) lässt die Zinssätze bei 0% stehen angesichts der weltweiten Straffung
Die Schweizer Zentralbank widersetzt sich globalen Zinserhöhungen, doch die Märkte erwarten einen Schritt bis Anfang 2027. Die Stärke des Schweizer Franken und die einzigartigen wirtschaftlichen Faktoren helfen, die Inflation niedrig zu halten.
Der Schweizer Markt hält sich stabil, während die US-Marktteilungen gemischt sind; der regulatorische Verlust von UBS belastet die Blue Chips
Der Schweizer Marktindex (SMI) pendelte sich etwa auf der Nulllinie ein, während UBS unter Verlusten stand, nachdem der Ständerat über strengere Kapitalanforderungen entschieden hatte. Die US-Marktteile öffneten sich gemischt, wobei die Futures des Nasdaq unverändert blieben, aber die Futures von Dow Jones und S&P 500 leicht stiegen.
Swiss franc rallies as USD/CHF drops below 0.8200, SNB warns of FX intervention
The Swiss franc strengthened against the dollar, with the pair slipping below 0.8200, while the SNB signaled readiness to intervene amid heightened Middle East risk.
Sygnum Partners With Nu Global to Bring Crypto Infrastructure to Latin America's Largest Digital Bank
Swiss crypto bank Sygnum will provide banking and custody infrastructure for Nu Global's international rollout, serving 140 million customers across Brazil, Mexico and Colombia.
Nestlé, Novartis, Roche and UBS: What Moves Switzerland’s Biggest Stocks?
Switzerland may be a relatively small country, but its stock market contains companies with enormous global influence.
SMI opens higher with Galderma, Sandoz debuts amid KI chip demand
Swiss equity markets expected to start the week on a positive note, with the SMI index poised for gains as pharmaceutical firms Galderma and Sandoz make their debut. Meanwhile, oil prices retreated despite escalating tensions in the Middle East.
Swiss Economic Calendar: SNB Policy Update, Federal Votes, Roche Pharma Day This Week
The Swiss National Bank will release its balance of payments and monetary policy assessment this week, alongside federal votes on Sep 27 and earnings from firms including Hilti, Hilti and Roche.
SMI opens higher; Fed rate-hike odds near 93% as traders wait for Wednesday decision
The Swiss benchmark rose 0.1% to 13,815.84 as ABB led gainers. Investors stayed cautious ahead of the Federal Reserve's rate decision, where a 25-bp hike is priced in at over 90%.
Der Schweizer Markt bleibt unter Druck, da US-Futures, Ölpreise und FX-Wechselkursbewegungen dominieren
Die asiatischen Märkte und die Schweizer Aktien stehen unter Druck durch die steigenden Brent-Rohölpreise, den Rückgang von US-Futures und die erwarteten Zinserhöhungen der US-Notenbank.
Der Schweizer SMI stieg vor dem Marktstart um 0,2%, da 18 der 20 Komponenten stieg
Alcon-Aktien fallen stark im Vorbörsestellene; Brent-Rohöl bleibt bei 100 USD angesichts geopolitischer Spannungen
Schweizer Wirtschaftskalender vom 10. bis 17. September: Ertrags- und Inflationsdaten sowie Politiker-Treffen
Zu den wichtigsten wirtschaftlichen Veröffentlichungen der Schweiz gehören die Inflationszahlen der BFS, die Halbjahresergebnisse von Repower und Helvetia Baloise, der Bericht der OECD zu den einzelnen Ländern sowie die bankrechtlichen Aussagen der UBS vor dem Staatsrat.
SMI gewinnt, da die Zinserhöhung von der Fed Entspannung bringt; UBS-Entscheidung verschoben
Die Schweizer Aktien weisen nach der von der US-Notenbank erwarteten Zinseinheit von 25 Basispunkten geringe Gewinne auf. Die Kapitalregel-Debatte bei der UBS beginnt nächste Woche.
Die Schweiz erhöht die Prognose für das BIP-Wachstum für 2026 auf 1,7 % aufgrund der Schwäche des Frankens
SECO erhöht seine Wachstumsprognose für 2026 von 0,9% auf 1,7% und führt dies auf stärkere als erwartete Q2-Daten und eine stärkere Frankenbewertung bei den Exporten zurück.
Die FINMA weist auf stabilen beaufsichtigten Einrichtungen in Abhängigkeit von den wachsenden globalen Risiken im Jahr 2025 hin
Der Schweizer Finanzaufsichtsbehörde zufolge blieben Banken und Versicherer während der geopolitischen Turbulenzen stabil, doch weisen sie auf Liquiditätslücken bei 8,2 % der Anleihefonds bei Stresstests hin.
Schweizer Wirtschaftskalender: Zinsentscheid der SNB, Unternehmensgewinne sind diese Woche wichtig
Der wirtschaftliche und branchenspezifische Kalender der Schweiz enthält Bewertungen der SNB, wichtige Ergebnisse sowie die Einführung von Strategien in den Bereichen Bankwesen, Immobilien und Industrie.
Infomaniaks Umkehrübernahme: Der 200-Millionen-Franken-Deal von Perrot Duval wirft Fragen zur Bewertung und Prognose auf
Ein Schweizer Anbieter von Cloud- und IT-Diensten fusioniert mit einem langjährigen, aber kämpfenden bürgertätigen Schweizer Unternehmen in einem Rollover-Übernahme-Verbund im Wert von 200 Millionen Schweizer Franken. Investoren stellen sich die Frage nach der Bewertung und den zukünftigen Perspektiven.
Bitcoin Suisse to Cut Up to Half Its Swiss Staff in Restructuring Push
The Zug-based crypto firm is laying off up to 50% of its local workforce as it pivots from domestic trading to global wealth management, relocating back-office operations to Bratislava and Vietnam.
Swiss Equity Favorites Add Two New Laggards; Sandoz Sets Ambitious 2035 Targets
Partners Group and Dätwyler anchor the bottom of the watchlist, while Sandoz unveils a plan to double revenue to over $22 billion by 2035.
Swiss Economic Calendar: Data Releases, Earnings Due Sept 15-22
Switzerland’s weekly financial calendar features Austrian and Swiss inflation data, SNB balance-of-payments figures, and H1 earnings from Addex, Curatis, Newron and others.
Partners Group reports H1 results; Layton steps down as CEO
Management income rises 6% to CHF 905m as AuM reaches USD 186bn; Co-CEOs Cagnati and Jenkner appointed effective January 2027.
Why Is the Swiss Franc So Strong — and What Does It Mean for Switzerland?
The Swiss franc has a reputation that extends far beyond the borders of Switzerland.
Gold or Swiss Franc? How Two Safe Havens Behave in Times of Crisis
When financial markets become nervous, two names frequently return to the conversation: gold and the Swiss franc.
Swiss stocks rise as Roche leads; Richemont falls on luxury sector weakness
Swiss Market Index edges up 0.12% as Roche gains on licensing deal, while Richemont drops 2.4% amid broader luxury sector decline. Swiss franc strengthens to 0.9384 per euro after August inflation surprise.
Swiss franc strengthens after higher-than-expected Swiss inflation data
The Swiss franc surged after August inflation rose to a two-year high, while the euro and dollar weakened. Analysts see potential SNB tightening in December, though energy-driven price gains may limit immediate action.
US stocks rise on Fed rate pause hopes; Swiss franc strengthens
Wall Street advances as investors bet on a September Fed pause, while the Swiss franc gains after higher-than-expected Swiss inflation. SMI mixed as Nestlé weighs on index.
Swiss stocks rise on US gains; Nestlé, Richemont drag; franc strengthens
Swiss Market Index edges up 0.2% after early 0.5% gain as Nestlé drags; Roche and Logitech lead gains. Euro falls to 0.9384 francs as Swiss inflation surprises.
US stocks rise on softer yields; Swiss franc strengthens after inflation surprise
U.S. benchmarks advance 0.4-0.6% at open as Treasury yields ease; SMI up 0.5% led by Roche and Logitech. Swiss inflation hits two-year high, lifting franc to 0.9392 per euro.
UBS identifies four European investment themes as earnings rebound gains traction
Strategists flag industrials, banks, quality leaders and Swiss mid-caps as Europe’s earnings cycle shifts from stagnation to growth, with 15% EPS growth forecast for 2026.
US stocks set for modest gain; SMI rises on Roche, Logitech gains; Swiss franc strengthens
U.S. futures point to a modestly higher open as Middle East tensions ease slightly. Swiss Market Index climbs 0.2% on Roche and Logitech gains, while the franc strengthens after Swiss inflation surprises.
US stocks cautious as oil prices rise; Swiss franc strengthens on inflation data
Dow Jones and Nasdaq futures show muted gains ahead of key U.S. jobs data, while rising oil prices and geopolitical tensions curb risk appetite. Swiss franc surges to 0.9392 per euro after unexpected inflation jump.
Swiss inflation hits two-year high, SNB rate hike odds rise
August CPI surge to 0.8% exceeds forecasts, lifting expectations for a potential Swiss National Bank rate increase by late 2027. Energy prices drive the jump while core inflation remains subdued.
Swiss stocks steady as SMI faces direction; Nestlé weighs, Swatch falls; franc strengthens
Swiss market opens flat with Nestlé down 0.67% while Swatch drops 2.3%; franc gains to 0.9392 per euro and 0.8092 per dollar after August inflation hits 0.8%.
Swiss office real estate resilient amid AI disruption risks
Raiffeisen study finds structural shifts in demand, with KI exposure and flexible work policies limiting office space cuts despite pandemic-era shifts. Leerage rates remain below pre-COVID levels.
Swiss shares rise as defensive stocks lead; gold rallies on softer jobs data
Swiss Market Index edges higher as Roche and other defensive stocks gain; gold jumps 0.63% on dovish US jobs report and weaker dollar. US semiconductor and software stocks diverge in premarket trading.
Swiss banks face CHF 12-24 bln mortgage funding gap under Basel III
New Basel III rules could leave a CHF 12-24 billion annual financing shortfall for Swiss real estate and development projects, while owner-occupied housing benefits from lower capital requirements.
Swiss stocks slip as oil, rate fears weigh on markets
SMI falls 0.4% as Brent crude tops $95, inflation and ECB/Fed policy expectations drive defensive rotation; Roche, Swiss Life gain while Amrize, Holcim lag.
Swiss equities slip as oil, inflation and rate fears weigh
SMI falls 0.4% to 14,280 as defensive shares lag; Amrize drops 2.7% after BofA downgrade, Roche and Swiss Life advance. Brent crude tops $95/bbl after U.S.-Iran strikes.
Swiss stocks fall as oil surge fuels inflation concerns; UBS upgrades Comet, VAT, Inficon
SMI drops 0.1% as Brent crude tops $95 a barrel after U.S.-Iran tensions escalate; UBS lifts targets on Swiss tech names. Nestlé to sell vitamins unit for $1 billion.
Swiss stocks slip as oil surges, geopolitical risks weigh on markets
The SMI fell 0.1% to 14,323 as Brent crude topped $95 a barrel amid U.S.-Iran tensions. Tech shares led gainers, while Amrize and Partners Group lagged.
Feintool swings to profit in H1 2026 on strong demand
Swiss automotive supplier posts 5.6% revenue growth to CHF 353.3m, EBITDA up 47% to CHF 34.1m as regional demand diverges.
Swiss equities rise as all SMI stocks gain; gold dips ahead of U.S. inflation data
The Swiss Market Index advances in early trade, led by Amrize, Kühne+Nagel and Logitech. Gold slips 0.3% to $4,642.74 per ounce as investors await the July PCE data and a speech by Fed’s Warsh.
Lindt & Sprüngli shares extend losses as key support looms
Premium chocolate maker’s stock falls 1.6% to 92,600 CHF, nearing a 52-week low of 91,900 CHF and risking a slide below 90,000 CHF. Reputational risks from U.S. lawsuit add pressure amid weak volume and pricing strategy concerns.
Lindt & Sprüngli shares slip toward 90,000 CHF as pressure mounts
Premium chocolate maker’s stock falls 1.6% to 92,600 CHF, nearing a 52-week low of 91,900 CHF. Legal risks and volume declines weigh on sentiment.
Rothschild & Co’s Swiss wealth unit posts record net new money inflow
Swiss unit records CHF800 million in net new client inflows in H1 2026, lifting AUM to CHF26 billion. Profitability pressured by 26% drop in net interest income amid strong franc.
Swiss equities slip on oil, Fed bets; Roche weighs on SMI
The Swiss Market Index fell 0.1% as Roche dragged, while Kühne+Nagel gained 1.4%. Brent crude rose 3.3% to $90.98 amid Middle East tensions and delayed Hormuz Strait talks.
Swiss stocks flat as oil rises, Fed rate hike bets weigh; Kühne+Nagel leads gains
The SMI traded little changed Monday as defensive stocks offset rising U.S. rate expectations and Brent crude topped $90 a barrel. Roche and Givaudan lagged while logistics firm Kühne+Nagel advanced.
Swiss Market Index shifts to 40% pharma weight after latest rebalancing
Healthcare now dominates the SMI after recent additions, raising concentration concerns but offering diversification within the sector itself.
UBS ranks Switzerland’s most desirable residential locations
UBS study finds medium-sized Swiss cities outperform large urban centers on cost and livability, with Freiburg, Solothurn and Aarau leading in affordability. Nine of ten regions favor mid-sized towns over metropolises.
Amrize CFO exits after five months as shares hit record low
Sam Poletti named successor to Baris Oran at struggling Swiss building materials group after shares breach key support. Investor pressure mounts amid inflation and margin concerns.
Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.
Swiss changes in September: Gotthard tunnel closures, dog bans and wage hikes
Switzerland implements new regulations including Gotthard tunnel night closures, a dog ban in Schwyz offices, Basel-Stadt wage increases, and revised federal prosecutorial rules. Ebookers halts Swiss bookings.
Swiss equities flat as Logitech, ABB rise; Amrize falls on CFO exit
The SMI traded little changed Tuesday, with Logitech and ABB leading gains while Amrize slumped after its finance chief departed. Swiss franc weakened against the dollar and euro as regional markets tracked mixed European cues.
UBS pushes for softer AT1 capital rules amid Swiss bank reform debate
Swiss lawmakers weigh compromise on Additional-Tier-1 debt as UBS-backed study argues for earlier loss-absorption triggers. Next vote set for Aug. 31.
Swiss stocks mixed as SMI edges higher; Arbonia plunges on earnings
ABB gains led gains among large caps while Arbonia slumped 9.8% after results; UBS and Vontobel adjusted ratings and price targets for several Swiss equities. The Swiss franc weakened further against the dollar and euro.
Swiss stocks rise as SMI nears record; Roche, Novartis lag; U.S. futures mixed
Swiss Market Index climbs 0.5% as construction shares lead gains; SAP downgraded by UBS despite raised price target. U.S. futures diverge ahead of Nvidia earnings and key data.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Helvetia launches mid-tier auto insurance covering total loss after collisions
New 'Totalschadenkasko' policy offers partial coverage plus total-loss protection after self-inflicted crashes at roughly one-third the cost of full collision insurance, Helvetia says. Demand strongest among owners of 10-year-old vehicles priced around 44,000 francs when new.
Swiss SMI dips 1% as Nestlé, Novartis, Roche weigh; Gurit surges 10%
Heavyweights drag Switzerland’s blue-chip index lower while Gurit jumps on strong earnings. Investors eye Jackson Hole for Fed clues amid elevated inflation and geopolitical risks.
Swiss SMI falls 0.8% as Nestlé, Novartis, Roche weigh; Gurit jumps 10%
Defensive heavyweights drag Switzerland's blue-chip index lower while chip-linked stocks rise on Nvidia earnings. Brent and WTI oil prices drop over 6% in a week amid Hormuz Strait talks.
UBS study: Mid-sized Swiss cities more attractive for families than Zurich, Geneva
Lower living costs and strong infrastructure in smaller urban centers outweigh benefits of major cities, UBS research finds. Study examines 10 Swiss regions with a two-child family model.
Kantonalbank expansion must be strategic, not just for growth: expert
Reto Jauch warns Swiss regional banks against expansion for its own sake, citing governance and strategic discipline as critical to success amid rising competition and technological change.
Swiss stocks rise pre-market; Accelleron surges on Nvidia-linked demand
SMI futures up 0.08% as Accelleron leads gains after strong half-year results. Brent and WTI oil drop over 1% on Hormuz Strait opening talks. Nvidia’s AI-driven rally boosts semiconductor suppliers.
Swiss equities rise as SMI gains 0.14% amid mixed sector moves
The Swiss Market Index advances modestly, supported by lower oil prices and U.S. equity strength. SoftwareOne and Stadler Rail shares surge on earnings beats, while Amrize leads decliners after record low.
SoftwareOne posts 68% revenue jump, Crayon integration nears completion
Swiss cloud and software provider SoftwareOne reports strong H1 2026 results, with revenue up 68% to CHF818M, though organic growth adjusted for Crayon stands at 11.6%. Net profit rises to CHF70.6M, EBITDA margin expands to 28.9%.
Swiss canton rejects plan to redistribute BLKB profits to municipalities
Baselland government opposes initiative to divert one-third of Basellandschaftliche Kantonalbank earnings to local communities, citing risk exposure and lack of ownership.
UBS-CFA indicator rises but uncertainty over Swiss economy grows
Swiss economic sentiment improves for second month, yet expectations diverge sharply; U.S. outlook darkens while SNB seen holding rates at zero. Euro seen above 0.90 CHF with 79% probability.
Stadler Rail posts record H1 2026 revenue but shares drop 22%
Swiss train maker Stadler Rail reported a 40% revenue jump to CHF 1.96 billion in H1 2026, yet its shares fell 22% as investors focused on weaker margins and negative free cash flow.
Swiss SMI gains 0.5% as construction, tech stocks lead gains
SMI advances toward record high as Amrize, Holcim and Stadler Rail surge; Roche and Novartis weigh on index. Nvidia earnings awaited after U.S. and Asian gains.
Stadler Rail shares surge 18% after strong half-year results
Swiss trainmaker posts 40% revenue growth, EBIT more than doubles, as stock rebounds from 2022 lows. Analysts upgrade outlook.
Rothschild & Co targets CHF 200 bln wealth AUM in Switzerland by 2027-29
Swiss unit posts record first-half net new money inflows as marquee brand and local acquisitions drive growth, despite headwinds from strong franc and weak rates.
Swiss equities edge higher as franc weakens; new price targets set
SMI futures rise 0.16% ahead of session; analyst revisions span Allreal, DKSH, Emmi and Sika. Swiss franc extends losses against dollar and euro as oil holds above $93.
US stocks slip at week’s open; Intel, AMD drag tech; SMI near lows
Dow, S&P 500 and Nasdaq 100 fall 0.1%, 0.3% and 0.6% respectively as chipmakers lag. Brent crude dips 1% to $93.22/bbl amid Iran sanctions outlook.
Swiss stocks end flat as ABB, pharma weigh; UBS, Vetropack rise
The SMI slipped 0.07% to 14,447 as investors took profits on ABB and sold off Roche and Novartis. UBS gained 1.7% and Vetropack surged 4.4% on company-specific news.
Swiss stocks rise as US futures gain; ABB, Logitech lead gains
Swiss Market Index climbs 0.21% as European peers advance; Amrize drops after CFO exit, Orior slumps on guidance cut. Oil, gold and crypto prices mixed.
EPIC Suisse posts 32% profit rise in H1 2026 on disposal gains, lifts guidance
Swiss real estate firm EPIC Suisse reported a 32.4% jump in net profit to CHF 39.8 million, driven by a CHF 9.4 million gain from the disposal of the Vennes III property. Full-year rental income growth guidance was raised to 1.5% from 1.0%.
Swiss equities flat as SMI hovers near 14,464; Logitech, ABB rise; Amrize falls
The Swiss Market Index edges 0.11% higher as Nestlé weighs on blue chips, while Logitech and ABB gain ground. Mid-cap and small-cap segments show mixed performance amid corporate updates and ratings changes.
Swiss stocks rise ahead of Nvidia earnings; Swiss franc weakens
Swiss Market Index up 0.16% premarket as Dow Jones gains 0.26%. Nvidia and Tesla shares fall ahead of chip giant's quarterly results. Brent crude holds above $93 per barrel amid regional tensions.
UBS sees Swiss rents rising despite record-low reference rate
Swiss mortgage reference rate to stay at 1.25% through 2027, but new rental contracts remain 15% higher than five years ago as supply tightens.
Swiss stocks slip as pharma giants weigh; Nestlé rises, biotech drags
SMI falls 0.25% to 14,423 as Roche and Novartis decline; Nestlé gains 0.5%. Biotech sector under pressure amid broader market caution ahead of key U.S. events.
Swiss market falls as Roche, Novartis weigh; Nestlé, Holcim rise
SMI slips 0.15% as pharma majors drag; Nestlé gains 0.5% while biotech stocks retreat. Brent oil drops 1.5% to $92.94 amid geopolitical jitters.
Swiss blue chips flat to open; SoftBank, KI stocks fall as Asia markets waver
Swiss franc strengthens versus euro and dollar as Asian equities drift lower on geopolitical risks and earnings caution. Brent crude dips 1.5% after prior week’s gains.
Former UBS CEO backs Swiss regulator in dispute with bank
Oswald Grübel, ex-CEO of UBS and Credit Suisse, sides with Finance Minister Karin Keller-Sutter against UBS's pushback on stricter capital rules. He argues state oversight is essential to prevent systemic risk.
Dollar outlook hinges on UST buybacks and Fed credibility, BofA says
Stronger U.S. Treasury buybacks and policy credibility concerns weigh on the greenback, with gold and franc outperforming as investors reassess dollar fundamentals.
Swiss nursing home costs top 10,000 francs monthly on average
Average stay exceeds two years, with monthly expenses ranging from 4,500 to 8,000 francs for residents. Public subsidies cover the remainder, but rising costs outpace pensions.
Swiss housing prices set to rise further; buyers face affordability squeeze
Rising real estate values and low mortgage costs are supporting Swiss home prices, but structural supply constraints and tax changes are reshaping affordability and investment decisions.
Roche issues CHF 410 million bond due 2036 with 1.095% coupon
The Swiss healthcare giant places a new 10-year Swiss franc bond at par, offering an annual yield of 1.095%. The issue is rated Aa2 by Moody's and trades from a minimum of 1,000 nominal units.
SNB’s Tschudin says negative rates remain an option in Switzerland
Swiss National Bank director Petra Tschudin cites anchored inflation expectations and a stable CPI basket as key factors behind record-low inflation. The central bank retains all policy tools, including sub-zero rates, to meet its 0-2% inflation target.
Swiss franc overtakes yen in carry trade as SNB cheers shift
The Swiss franc has become the preferred funding currency for new carry trades, displacing the yen as global investors seek lower volatility and stable yields. The shift benefits the SNB and Swiss exporters amid a fragile market backdrop.
Swiss wealth managers face high compliance costs under TBTF rules
Regulatory burdens for small Swiss asset managers under new rules exceed CHF 50,000 annually per firm, raising concerns over proportionality and transparency in Finma oversight.
Swiss gasoline prices rise above 2 francs per liter for first time since 2022
Average price for 95-octane gasoline reaches 2.02 francs per liter, driven by Middle East tensions, reduced refinery capacity and Rhine transport disruptions. Diesel climbs to 2.27 francs.
US equities mixed; SMI edges lower as oil hits four-week high
Futures on the Dow slipped 0.13% while Nasdaq futures rose 0.1% ahead of U.S. open. Brent crude surged 2.6% to $94.04/bbl, nearing $100/bbl. Swiss Re and Logitech led SMI laggards.
Switzerland secures gas supply option via France-Italy pipeline
Bund and gas industry arrange fallback gas access for winter 2026-27. Option covers about 10% of projected winter demand. Costs capped at low single-digit millions, shared across all gas users.
Swiss ETF savings plans surge 44.6% in H1 2026, led by global index funds
Broadly diversified world ETFs dominate Swiss savings plans despite AI and ESG hype, with monthly volume up 29% in Europe. Swiss adoption remains low at 9% of investors.
Swiss stocks edge higher as Roche, Novartis offset losses; Logitech slides
SMI gains 0.1% as healthcare giants support index; Logitech drops 1.3% after JP Morgan downgrade. Oil holds near $92, gold dips as yields fall.
LGT posts 17% profit rise in H1 2026 as assets under management hit record
Group net profit rose to 281.6 million francs as revenues climbed 5% to 1.49 billion francs, with net new money inflows reaching 12.3 billion francs. Managed assets surged 7% to a record 412.6 billion francs.
Swiss equities edge higher as Roche, Novartis offset Logitech decline
SMI advances 0.1% on pharma strength; Centiel surges 18% after analyst upgrade. Oil holds near $92/bbl as geopolitical risks persist.
Swiss SMI rebounds into positive territory after midday losses
The SMI turned positive by 0.15% after trading lower all day, with Roche and Novartis narrowing declines. Brent crude held above $93 a barrel amid Middle East tensions.
Swiss stocks rise as 19 of 20 SMI components gain; Roche leads, Aryzta slumps
The SMI advanced 0.12-0.16% with Roche up 0.52% as 19 of 20 index members gained. Aryzta tumbled over 6% after UBS downgraded it to sell amid broader market strength.
Siegfried shares jump 6.7% after strong H1 2026 results
Swiss pharma services firm posts CHF 633 million in revenue, beats estimates on organic growth and drug substance sales. Stock nears 52-week high.
Swiss corporate earnings, economic data due next week
First-half results from Swiss firms and key macro releases are scheduled for Aug. 20-27, including UBS-CFA index, Swissmem tech data and SBB H1 outlook.
Swiss SMI posts second straight weekly loss as pharma, Partners Group slide
The Swiss Market Index falls 0.34% to 14,319.29 as Roche, Novartis and Partners Group weigh on blue chips. Brent crude holds above $93 a barrel amid Middle East tensions.
Analysis: US Treasury buybacks seen supporting softer dollar, risk appetite
Analysts argue the latest US Treasury intervention signals concern over high bond yields rather than a policy credibility crisis, potentially aiding high-beta and emerging market currencies.
USD/CHF bears regain control as Swiss franc draws haven flows
U.S. Treasury’s expanded long-end buybacks and shifting correlations fuel safe-haven demand for the franc, pushing USD/CHF below key support. Technicals and fundamentals suggest further downside if resistance holds.
Swiss EAMs face eight key trends amid market shifts
Consolidation, specialization and evolving client needs are reshaping Switzerland’s independent wealth management sector, with professionalization and risk management gaining prominence.
Swiss borrowers overpay by CHF 18,000/year on long-term mortgages
Households refinancing into decade-long fixed-rate loans during 2023’s brief high-rate window now face annual overpayments of up to CHF 18,000 versus Saron-linked or short-term options, data shows.
Carry traders target Swiss franc as yen loses appeal
Hedge funds boosted net short positions in the Swiss franc to a two-month high as yen carry trades face volatility after recent interventions. Analysts cite low Swiss rates and SNB intervention risks as key drivers.
Geberit posts strong Q2 2026 results, raises full-year outlook
Swiss plumbing supplier reports 5.9% organic sales growth in first half of 2026 despite currency headwinds, with EPS up 7.9% and EBITDA margin steady at 30.9%.
BKW AG posts 7% rise in H1 2026 net profit despite lower operating earnings
Swiss utility BKW AG reported CHF 217.6 million in net profit for the first half of 2026, up 7% year-over-year, while operating earnings declined. The company maintained its full-year EBIT guidance range.
BKW shares fall after H1 profit drops, 2026 EBIT outlook cut
Swiss energy group BKW reported a 15% drop in H1 EBIT and confirmed a lower-end 2026 earnings target. Shares fell more than 1% as energy market headwinds weighed on performance.
U.S. accused of interest-rate manipulation after doubling bond buybacks
Criticism of the Swiss National Bank’s currency interventions highlights parallels with Washington’s bond-market interventions, which similarly distort market pricing. Analysis of policy overlap and unintended consequences.
Swiss utility BKW shares fall 1.1% on weak H1 2026 results
BKW AG reported a 3.1% drop in operating income to CHF 2.18 billion, with EBITDA and EBIT declining 10.1% and 15.1%, respectively. Net profit rose 7% to CHF 217.6 million.
Geberit shares jump 7.1% on strong first-half sales growth
Swiss plumbing group posts ninth straight quarter of currency-adjusted sales growth, lifts full-year guidance. Shares rise to CHF 564.2.
Swiss SMI edges higher; Geberit surges 8% on strong half-year results
Swiss SMI opens 0.21% higher as Geberit leads gains with an 8% jump following better-than-expected half-year earnings. Implenia, Sensirion and Sunrise also advance, while Straumann, BKW and Emmi decline.
Straumann reports 2.3% revenue growth in H1, CEO Daniellot to step down
Swiss dental implant maker posts 1.38 billion francs in first-half sales, trims full-year outlook amid leadership transition.
Swiss SMI rises 0.21% as oil climbs fourth day; Geberit, Implenia surge on earnings
Geberit surged 8% after beating half-year expectations, while Implenia jumped 9% on strong growth outlook. Brent crude rose 0.7% to $91.61 as Iran conflict persists; BKW and Straumann fell 4.5%.
Viseca posts 6.2% profit drop in H1 2026 despite transaction growth
Swiss payments provider Viseca reports lower net income as interest and fee revenues decline, offsetting higher transaction volumes and card issuance growth.
Swiss SMI slips as 19 of 20 components fall; Geberit, DocMorris advance on earnings
The Swiss blue-chip index was set to open lower, with Geberit the sole gainer after strong half-year results. DocMorris surged 8% on earnings, while BKW dropped 3%. Global yields near multi-decade highs weighed on risk assets.
Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook
Swiss dairy group Emmi reports stronger-than-expected first-half growth, with revenue up 2.2% to CHF 2.32bn, while maintaining full-year EBIT and net margin guidance.
Swiss SMI slips on rising yields; Geberit earnings loom, oil climbs
Swiss benchmark down 0.13% as global bond yields hit multi-decade highs; Geberit to report half-year results. Oil rises on Hormuz Strait risks as tech stocks retreat.
Swiss franc gains appeal for carry trades after yen intervention
Investors shift focus to the franc as a funding currency for carry trades following rare yen intervention. Swiss franc strengthens against the euro and dollar while rates remain at zero.
Swiss SMI gains 0.5% as Geberit, Roche lead; Alcon, insurers lag
Defensive heavyweights and strong earnings from Geberit drove the Swiss benchmark higher, while Alcon and insurance stocks declined. Second-tier movers included Implenia, Skan and LLB on results.
Global stocks slip as yields surge; Swiss market edges up on pharma gains
Nasdaq leads losses as U.S. 30-year yields hit 19-year high. SMI ekes out gains on Roche, Novartis gains; ABB falls. Brent crude near $91, gold dips.
Sunrise Q2 2026 results: cash flow rises 33% as revenue dips 2.6%
Swiss telecom group reports CHF 204 million adjusted free cash flow in Q2, offsetting a 2.6% revenue decline. Full-year guidance maintained despite softer top-line trends.
Swiss Market Index slips as Geberit surges; oil hits four-day high
Geberit shares jumped 8% on strong half-year results while Straumann fell 6.3% after CEO departure. Brent crude rose above $92 as geopolitical risks mount.
Dollar, euro lose nearly half their purchasing power since 2000
U.S. dollar and euro purchasing power halved over 25 years, while Swiss franc held value better amid divergent central bank policies. Inflation trends and wage dynamics compared.
Swiss stocks slip as global markets waver; Roche, Novartis advance
Swiss Market Index fell 0.13% as U.S. futures declined on rising bond yields and Middle East tensions. Roche and Novartis led Swiss gains, while cyclicals like ABB lagged. U.S. tech and AI-linked stocks retreated.
Swiss GDP grows 1.5% in Q2 2026, data shows
Switzerland's economy expanded at a faster-than-expected pace in the second quarter, driven by domestic demand and services sector growth.
Swiss National Bank holds rates steady as inflation cools
The SNB maintained its policy rate at 1.25% on Thursday, citing stable inflation and economic resilience. No further guidance on future moves was provided.
Swiss National Bank holds rates steady after September review
The SNB left its key policy rate unchanged at 1.25% as inflation remains within target range, citing stable economic conditions.